batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ASCO-GU – subcutaneous Opdivo puts the pressure on Merck 30 January 2024 Roche walks away from Hookipa’s KRAS immunotherapy 29 January 2024 Kura’s PIPE dream 25 January 2024 Targeted bladder cancer treatment evolves 23 January 2024 ASCO-GI – early casdozokitug celebration for Coherus 22 January 2024 Trodelvy throws second-line lung cancer another curveball 22 January 2024 ASCO-GI – Novartis looks for earlier Lutathera use 19 January 2024 ASCO-GI – investors want a better look before they Leap 18 January 2024 Load More